Abstract
This review analyze data of clinical trials, systematic reviews and meta-analyses, which evaluated the sensitivity and specificity of any biomarkers using for diagnostics of prostate cancer before an initial prostate biopsy or after a negative initial biopsy.
Highlights
Summary
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have